📢 Reflecting on One Year of EU HTA Regulation: The Patient Perspective CPE participated in the @eupatientsforum.bsky.social webinar “One Year of HTA Regulation Implementation – What Has Changed for Patients?” ➡️ Read more: lnkd.in/eG4vaAgq

🌟 CPE is proud to support My Cancer Navigator! Offered by the Anticancer Fund, My Cancer Navigator provides trusted guidance for patients, families, and healthcare professionals navigating cancer care. 🔗Learn more: mycancernavigator.org/en

🌐 Don't miss the Mission Early's webinar on “Defining the ideal framework for early cancer care – key takeaways from WCLS and next steps” 🗓️26 January 2026 ⏰2.30-3.30 pm CET ➡️ Register here: lnkd.in/evdCW6Yy

📢 Register for the INSPIRE Project Final Symposium 📅 16 May 2026 📍 Prague | O₂ Universum 🕑 14:00–17:00 CET ➡️ Register now: lnkd.in/eT4puc2F 🔗 Learn more about the event: lnkd.in/en8hHmFF

📅 SAVE THE DATE Join us to explore the results of our pan-European survey on nutritional support for cancer patients and survivors. 🗓️ 3 February 2026, 17:00 – 19:00 CET 📍European Parliament, SPINELLI A8F388 ➡️ Register here: lnkd.in/epDRmxgf

🚭 Webinar | Interferencia de la industria del tabaco en España Nuestro presidente, @frguez.bsky.social, aportará la perspectiva de los pacientes. 📅 16 de enero de 2026 | ⏰ 14:00 CET ➡️ Inscripción: lnkd.in/emfTWY4G

New medicine to treat non-muscle invasive bladder cancer | European Medicines Agency (EMA) www.ema.europa.eu/en/news/new-...

📢 #AMR Awareness Week CPE will continue pushing for evidence-based, patient-led policies that safeguard the future of cancer treatment across Europe. 🔗 Read more: lnkd.in/dh2YJWyB

📢 CPE at the European Health Workforce and Care Strategy Forum in Brussels We believes that supporting the healthcare workforce is essential, because stronger professionals mean better care for patients. 🔗 Learn more: lnkd.in/d-eKtct9

📢 #AMR Awareness Week: Why Antibiotics Matter for Cancer Patients 🔗Read more: lnkd.in/dwKuha3D

🎗️ #LungCancerAwarenessMonth - Support Matters! This November, CPE is proud to support @lungcancereurope.bsky.social 2025 #GetSupported campaign, focusing on the essential support patients need after diagnosis. 🔗 Learn more: getchecked.eu

"Around 50% of cancer deaths are linked to infection, and mortality rises sharply when those infections are resistant." ➡️CPE will continue pushing to make #AMR a central priority in cancer policy across Europe. 🔗 Read more: lnkd.in/dcX-75WN

📢Perception of Targeted Radiotherapy in Europe. Your Experience Matters! ➡️Take the survey: lnkd.in/di7nW5cr 🔗Learn more: lnkd.in/di7nW5cr

➡️Don’t Miss It! 🗓 Date: Thursday, 27 November 2025 🕞 Time: 15:30 – 17:00 CET 📍 Location: Online

📢 We’re Hiring! CPE is looking for an Events Officer to join our team in the heart of Brussels! 📆 Apply by December 19th, 2025 ➡️ Details and application: lnkd.in/dmWh2vqA

🩺 #EHS2025: Panel Announcement "Investing in Health: The Case for Smarter Economies & Healthier Futures". 🗣Featuring speakers from Minister for Health and Active Ageing -Government of Malta, Pfizer, Astellas, @eib.org, and @cancerpatientseu.bsky.social. Register now: ebsummits.eu/our-summits/...

📢 CPE at the European Huntington Association (EHA) Workshop: Ensuring Meaningful Patient Involvement in EU HTA Processes ➡️ Read more: lnkd.in/dQMjBYKP

📢 Join us on 1 December (14:00–15:00 CET) for the launch of our new report co-authored with the EFPIA - European Federation of Pharmaceutical Industries and Associations Oncology Platform. ➡️ Register here: lnkd.in/d5cSz_d2

📢 CPE at #WCLS2025 CPE remains committed to keeping the patient voice central in cancer policy, advocating for coordinated action, equitable access, and meaningful community engagement. 🔗 Learn more: lnkd.in/dMtgD4Gc

📢 CPE at the European Health Summit 2025 🔗 Learn more: lnkd.in/e4YXsPjf 📄 Read our European Semester Manifesto: lnkd.in/e4YXsPjf

📢 CPE at the European Parliament: Highlighting the importance of patient perspectives in EU health policy. CPE continues to advocate for integrating patient voices in policy & care across Europe. 🔗Read more: lnkd.in/e-4fETVy

📢 Advancing Cancer Policy CPE & EFPIA launched the EBCP-NCCP Implementation Study to drive real-world impact in national cancer strategies. 🔗 Learn more: lnkd.in/et2bnmgu ➡️ Read the Report: lnkd.in/ewXtTAdc

📢 CPE at the 7th European Cancer Forum in Brussels CPE highlighted the patient perspective, calling for a European Semester on cancer, robust data & meaningful patient involvement. 🔗Read more: lnkd.in/euF3QFMQCPE

📢 CPE welcomes #EPPerMed's decision to allocate dedicated funding for patient organisations 🔗 Read more: lnkd.in/edHVvJcZ ➡️ Learn more about EP PerMed: eppermed.eu

📢Register now for the INSPIRE final symposium! 📅 16 May 2026 📍 Prague | O₂ Universum 🕑 14:00–17:00 CET 🔗 Registration is free and open: lnkd.in/dxgsncWU ➡️ Read more about INSPIRE event: lnkd.in/en8hHmFF

20 años de la ley del tabaco youtu.be/QYszQ3A3nJY?...

🎙️Don’t miss it! Webinar “How to Unlock Patient Insights Through Patient Advocacy Group Collaboration” 🗓️ 22 October 🕔 5 PM CEST / 11 AM EST 🔗 Register now: lnkd.in/dUC2M3xT 👉 Learn more: lnkd.in/ddMFDibP

🚨 New Brachytherapy Patient Survey! CPE would like to hear from cancer patients about their awareness & access to brachytherapy, a targeted radiation treatment that can improve outcomes & reduce side effects. Your voice matters! 👉 Take the survey: lnkd.in/di7nW5cr

💊 A strong EU biosimilar policy is key to progress in cancer care. Don't miss our event “Building Equity, Access & Sustainability in Cancer Care with an EU Biosimilar Policy & Strategy” 📍4 Nov 2025, @europarl.europa.eu ⏰09:00-10:30 Registrations: lnkd.in/di6H7kHd

💊 20 years of biosimilars in Europe. Let’s keep building equitable access for all patients. Don't miss our event at the @europarl.europa.eu: 📍SPINELLI 1G369 🗓️4 November 2025 (9:00-10:30) 🔗Registrations: lnkd.in/di6H7kHd ➡️Learn more: lnkd.in/d4GGyxY8

📢 CPE joined the 6th HTA Stakeholder Network Meeting in Brussels to champion meaningful patient input in JCA. Together with the European Patients Forum, CPE is co-leading a new project to strengthen patient and caregiver voices in EU HTA. 🔗 Learn more: lnkd.in/diVgKTfa

⌛One week to go! 📢Registrations close on thursday! lnkd.in/di6H7kHd Join us at the @europarl.europa.eu on 4 November for our event "Building Equity, Access & Sustainability in Cancer Care with an EU Biosimilar Policy & Strategy". 💡Why attend? lnkd.in/dgsRSmp3

📢 CPE at the World Orphan Drug Congress Europe 2025: Advancing patient involvement in JCAs for ATMPs. CPE highlighted the need for early, structured patient input to ensure faster, fairer access across Europe. 🔗 Read more: lnkd.in/d9-ZbxM3

📢 CPE at the EACR–OECI Virtual Event: Patient Involvement in Cancer Research Patient involvement is not optional, but essential to delivering better, more equitable cancer research and care. 🔗 Learn more: lnkd.in/g7XqjknM

🎗️October is Breast Cancer Awareness Month 2025 🩷 Together, let’s close the knowledge and access gaps in breast cancer care. 🔗 Learn more about our work on Genomic Testing: lnkd.in/dT39mg_U 🔗 Learn more on our ESR1 & Liquid Biopsy project: lnkd.in/d2ygNAXC

📢 Continuing the Momentum for Pancreatic Cancer Across Europe 👉 Read the full update on progress and next steps: lnkd.in/gE2CePqy

📢 CPE at the PREVENT 4th Plenary Meeting in Gorizia! CPE remains committed to patient-centred engagement, supporting PREVENT in promoting healthy lifestyles for children across Europe. 🔗 Learn more: lnkd.in/dFprNDcd